Skip to Content

Delaware Ivy Value C IYVCX

Medalist Rating as of | See Macquarie Investment Hub
  • NAV / 1-Day Return 15.52  /  +0.06 %
  • Total Assets 487.4 Mil
  • Adj. Expense Ratio
    1.830%
  • Expense Ratio 1.830%
  • Distribution Fee Level Above Average
  • Share Class Type Level Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.66%
  • Turnover 103%

USD | NAV as of Mar 02, 2024 | 1-Day Return as of Mar 02, 2024, 1:27 AM GMT+0

Morningstar’s Analysis IYVCX

Will IYVCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Delaware Ivy Value C's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IYVCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 31.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Duke Energy Corp

3.20 16.4 Mil
Utilities

Johnson & Johnson

3.20 16.4 Mil
Healthcare

Teledyne Technologies Inc

3.18 16.3 Mil
Technology

DuPont de Nemours Inc

3.17 16.3 Mil
Basic Materials

RTX Corp

3.17 16.3 Mil
Industrials

TJX Companies Inc

3.16 16.2 Mil
Consumer Cyclical

Merck & Co Inc

3.16 16.2 Mil
Healthcare

American International Group Inc

3.15 16.2 Mil
Financial Services

CVS Health Corp

3.15 16.2 Mil
Healthcare

Dollar Tree Inc

3.15 16.2 Mil
Consumer Defensive